What's breaking now, across thousands of outlets.
Lilly intends to merge its U.S. and international divisions when a top executive retires. Elsewhere, Astellas closed in on what it believes to be a “best-in-class” cancer immunotherapy prospect.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Civil society groups urge U.S.-based Global Alliance for TB Drug Development to withdraw related patent claims in other countries
NIH Director Jay Bhattacharya, despite his many faults, did recommend a very accomplished and appropriate scientist to the post of National Institute of Mental Health (NIMH), Vikaas Sohal.
Medicare navigation company Chapter is expanding its ambitions in retirement support with the acquisition of Hively, a personalized retirement navigation and membership platform.
As Pinktober brings renewed attention to breast cancer awareness, a women-led motorcycle rally took to the streets of Karachi last Sunday, bringing together female riders, organisers and a medical…
